Calopad, the world's thinnest MDR/FDA-certified wearable for targeted, side-effect-free heat and cold therapy for pain relief and recovery.
Calopad has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in August 2023.
Calopad's investors include Technology Fund.
Calopad is headquartered in Lucerne, Switzerland.
Calopad, the world's thinnest MDR/FDA-certified wearable for targeted, side-effect-free heat and cold therapy for pain relief and recovery.
Calopad is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Calopad — Funding & Investors." VCBacked, August 25, 2023, https://www.vcbacked.co/company/calopad. Accessed September 14, 2026.
VCBacked. (2023). Calopad — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/calopad
{{cite web |title=Calopad — Funding & Investors |url=https://www.vcbacked.co/company/calopad |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated